Technology and Innovation

Lab-grown organoids show how SARS-CoV-2 infects brain cells.

Malaria parasite is seen as unlikely to evolve defenses against the multi-attack approach, research from Johns Hopkins Bloomberg School of Public Health finds.

The U.S. Food and Drug Administration approved a clinical trial Friday that will allow Johns Hopkins University researchers to test a therapy for COVID-19 that uses plasma from recovering patients.

Researchers at JHSPH have discovered a fundamental mechanism that regulates gene activity in cells. The newly discovered mechanism targets RNA, or ribonucleic acid, a close cousin of DNA that plays an important role in cellular activity.

A suicide risk screening tool that Johns Hopkins Medicine implemented appears to provide an accurate gauge of which youth are most vulnerable and has identified more than 2,000 patients who might benefit from mental health treatment and resources.